STOCK TITAN

LFWD - LFWD STOCK NEWS

Welcome to our dedicated news page for LFWD (Ticker: LFWD), a resource for investors and traders seeking the latest updates and insights on LFWD.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect LFWD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of LFWD's position in the market.

Rhea-AI Summary
Lifeward appoints Mike Swinford, an experienced healthcare and rehabilitation technology professional, to its Board of Directors. Swinford brings over 30 years of expertise in commercialization and new business development, having served as the CEO of Numotion and in various roles at GE Healthcare. His appointment aims to strengthen Lifeward's leadership in delivering life-changing solutions for individuals with physical limitations or disabilities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
-
Rhea-AI Summary
ReWalk Robotics (Nasdaq: LFWD) announces finalized Medicare reimbursement pathway for personal exoskeletons, expanding access for eligible beneficiaries. CMS sets final lump-sum purchase fee schedule amount, providing clarity for physicians and patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.59%
Tags
none
-
Rhea-AI Summary
ReWalk Robotics (LFWD) collaborates with CMS to determine final payment rate for ReWalk Exoskeletons. CMS to update fee schedule after April 1.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.2%
Tags
none
Rhea-AI Summary
ReWalk Robotics (DBA Lifeward™), a global leader in assistive technologies, applauds the introduction of a Senate companion bill to H.R. 6373, the VA Spinal Trauma Access to New Devices (STAND) Act. The legislation aims to provide annual examinations and assessments for assistive technologies, including Personal Exoskeletons, for Veterans with Spinal Cord Injury, increasing access to life-changing solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.29%
Tags
none
-
News
Rhea-AI Summary
ReWalk Robotics Ltd. (LFWD) announces a 1-for-7 reverse split to meet Nasdaq listing standards. The split aims to increase share price above $1.00 while reducing outstanding shares. The split will apply to warrants and stock options, with issued shares decreasing from 60.1 million to 8.6 million post-split.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.5%
Tags
-
Rhea-AI Summary
Two recent research publications highlight the effectiveness of the ReStore Exo-Suit in improving walking ability for post-stroke patients. The studies show significant improvements in walking speed and distance, emphasizing the clinical value of Lifeward's technology for rehabilitation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.9%
Tags
none
Rhea-AI Summary
ReWalk Robotics Ltd. (Nasdaq: LFWD) announced a deferral in pricing decision for personal exoskeletons by CMS, with payment determination on a case-by-case basis until finalized. Lifeward has provided 35 exoskeletons to Medicare beneficiaries to support demand.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.29%
Tags
none
-
Rhea-AI Summary
ReWalk Robotics Ltd. (DBA Lifeward) reported record annual revenue of $13.9 million in 2023, a 151% increase from 2022. The integration of commercial and operational resources led to $3 million in annual net savings. The company unveiled its new branding as Lifeward and benefitted from CMS including exoskeletons in the Medicare brace benefit category. Fourth-quarter revenue was $6.9 million, up 216% from 2022, with a gross margin of 35.5%. Operating expenses were $8.6 million, resulting in an operating loss of $6.1 million. Net loss was $5.6 million. The company had $28.1 million in cash and expects 2024 revenue between $28 to $32 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.32%
Tags
-
Rhea-AI Summary
ReWalk Robotics Ltd. (Nasdaq: LFWD) to release fourth quarter and fiscal year-end 2023 financial results on February 27, 2024. Conference call with CEO and CFO to discuss financial results. Webcast available on GoLifeward.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
conferences earnings
Rhea-AI Summary
ReWalk Robotics Ltd. rebrands as Lifeward, unveiling a new name, stock ticker, logo, website, and corporate messaging. The company aims to empower individuals facing physical limitations or disabilities by delivering innovative solutions like the AlterG Anti-Gravity systems. The rebrand reflects the broader goal of elevating the standard of care in rehabilitation and driving growth through a unified commercial team. The new stock ticker 'LFWD' will be effective from January 30, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.06%
Tags
none
LFWD

Nasdaq:LFWD

LFWD Rankings

LFWD Stock Data